40
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Heat shock protein 60 and cardiovascular diseases: An intricate love‐hate story

      review-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cardiovascular diseases (CVDs) are the result of complex pathophysiological processes in the tissues comprising the heart and blood vessels. Inflammation is the main culprit for the development of cardiovascular dysfunction, and it may be traced to cellular stress events including apoptosis, oxidative and shear stress, and cellular and humoral immune responses, all of which impair the system's structure and function. An intracellular chaperone, heat shock protein 60 (HSP60) is an intriguing example of a protein that may both be an ally and a foe for cardiovascular homeostasis; on one hand providing protection against cellular injury, and on the other triggering damaging responses through innate and adaptive immunity. In this review we will discuss the functions of HSP60 and its effects on cells and the immune system regulation, only to later address its implications in the development and progression of CVD. Lastly, we summarize the outcome of various studies targeting HSP60 as a potential therapeutic strategy for cardiovascular and other diseases.

          Related collections

          Most cited references208

          • Record: found
          • Abstract: found
          • Article: found

          2020 International Society of Hypertension Global Hypertension Practice Guidelines

            • Record: found
            • Abstract: found
            • Article: not found

            Molecular chaperones in protein folding and proteostasis.

            Most proteins must fold into defined three-dimensional structures to gain functional activity. But in the cellular environment, newly synthesized proteins are at great risk of aberrant folding and aggregation, potentially forming toxic species. To avoid these dangers, cells invest in a complex network of molecular chaperones, which use ingenious mechanisms to prevent aggregation and promote efficient folding. Because protein molecules are highly dynamic, constant chaperone surveillance is required to ensure protein homeostasis (proteostasis). Recent advances suggest that an age-related decline in proteostasis capacity allows the manifestation of various protein-aggregation diseases, including Alzheimer's disease and Parkinson's disease. Interventions in these and numerous other pathological states may spring from a detailed understanding of the pathways underlying proteome maintenance.
              • Record: found
              • Abstract: found
              • Article: not found

              The HSP90 chaperone machinery

              The heat shock protein 90 (HSP90) chaperone machinery is a key regulator of proteostasis. Recent progress has shed light on the interactions of HSP90 with its clients and co-chaperones, and on their functional implications. This opens up new avenues for the development of drugs that target HSP90, which could be valuable for the treatment of cancers and protein-misfolding diseases.

                Author and article information

                Journal
                Med Res Rev
                Med Res Rev
                10.1002/(ISSN)1098-1128
                MED
                Medicinal Research Reviews
                John Wiley and Sons Inc. (Hoboken )
                0198-6325
                1098-1128
                17 August 2020
                January 2021
                : 41
                : 1 ( doiID: 10.1002/med.v41.1 )
                : 29-71
                Affiliations
                [ 1 ] Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Medicina Cardiovascular y Metabolómica Monterrey Nuevo León México
                [ 2 ] Methodist DeBakey Heart and Vascular Center, The Methodist Hospital Houston Texas
                [ 3 ] Veterans Affairs Medical Center Sacramento California USA
                [ 4 ] Department of Internal Medicine, Molecular and Cellular Cardiology, Cardiovascular Division University of California Davis California USA
                [ 5 ] Department of Pharmacology University of California Davis California USA
                [ 6 ] Tecnologico de Monterrey, Hospital Zambrano Hellion, TecSalud, Centro de Investigación Biomédica San Pedro Garza García Nuevo León México
                Author notes
                [*] Correspondence C. Enrique Guerrero‐Beltrán, Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Medicina Cardiovascular y Metabolómica, Monterrey, Nuevo León 64710, México.

                Email: EnriqueGuerrero@ 123456tec.mx

                Author information
                https://orcid.org/0000-0002-3314-2609
                https://orcid.org/0000-0002-5001-0093
                Article
                MED21723
                10.1002/med.21723
                9290735
                32808366
                23b01df1-18d4-421b-b1fa-aa8b334ce007
                © 2020 The Authors. Medicinal Research Reviews published by Wiley Periodicals LLC.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 03 August 2020
                : 10 June 2020
                : 05 August 2020
                Page count
                Figures: 3, Tables: 3, Pages: 43, Words: 24621
                Funding
                Funded by: Cardiovascular Medicine Research Group‐Tecnologico de Monterrey
                Award ID: 0020CAT131 (to C. Enrique Guerrero‐Beltrán)
                Categories
                Review Article
                Review Articles
                Custom metadata
                2.0
                January 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:18.07.2022

                heart diseases,heart failure,heat shock proteins,immunity,therapeutic

                Comments

                Comment on this article

                Related Documents Log
                scite_

                Similar content501

                Cited by14

                Most referenced authors2,800